The Feasibility Of a Daily Diary Methodology With a Pediatric Cancer Population
DIARY1
1 other identifier
observational
154
1 country
1
Brief Summary
This investigation seeks to determine the feasibility of an electronic diary methodology among pediatric cancer patients and healthy matched controls. Levels of study participation and compliance will be assessed to assist with determining overall feasibility. Results will offer insight into the effectiveness of this means of data collection with a pediatric oncology population, and will examine how psychosocial and contextual factors contribute to the resiliency that has been demonstrated by children with cancer. Findings will provide data for the design and implementation of a future, larger-scale study with this pediatric population that implements an electronic daily diary methodology.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 15, 2011
CompletedFirst Posted
Study publicly available on registry
November 22, 2011
CompletedStudy Start
First participant enrolled
December 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2016
CompletedApril 8, 2016
April 1, 2016
4.3 years
November 15, 2011
April 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The number who agree to participate compared to the total number approached for the study.
The rate of agreement to participate in the study.
Day 0 of study
The number of total days the participant was able to complete the daily diary.
The rate of completion of daily diary measures, and the number of participants who complete the study in its entirety.
From on-study date through up to 4 months
Study Arms (2)
Cancer patient
Patient participants will include children and adolescents between the ages of 8-17 years who have been recently diagnosed with cancer. They will use an iPad as a diary to track their daily experiences. They will use an iPad as a diary to track their daily experiences.
Control
For each pediatric patient enrolled, a child without a history of a serious medical illness will be recruited from the larger community who is matched on variables of age, race/ethnicity, gender, and socioeconomic status. They will use an iPad as a diary to track their daily experiences. They will use an iPad as a diary to track their daily experiences.
Interventions
The proposed investigation is a prospective case-control pilot study. The major goal of this pilot study is to assess the feasibility of a daily diary methodology for monitoring the experiences of recently diagnosed pediatric cancer patients and healthy-matched peers. The investigation will also examine the relationships among individual and contextual factors that influence the daily psychosocial functioning of youth with cancer in comparison to youth without cancer.
Eligibility Criteria
All eligible participants will be invited to participate in the research investigation, including children and parents of both genders and of all races/ethnicities. St. Jude treats pediatric patients from across the country and around the world, which results in a culturally diverse pediatric population. Based upon enrollment patterns from previous investigations, it is anticipated that approximately 19% of enrolled pediatric participants will be racial/ethnic minority children. Because the control group will be matched to the pediatric group on variables of gender, age, race/ethnicity, and socioeconomic status, it is anticipated that the gender and race/ethnicity of the control group will be commensurate with that of the pediatric group.
You may qualify if:
- Research participant is between ages 8 and 17 years inclusive.
- Research participant has received a diagnosis of malignancy in the period 10 weeks prior to enrollment.
- Research participant has no significant cognitive, motor, or sensory deficits that would preclude completion of the study measures.
- Research participant is able to speak and read English.
- Research participant is between ages 8 and 17 years inclusive.
- Research participant has no history of a major medical diagnosis.
- Research participant has no significant cognitive, motor, or sensory deficits that would preclude completion of the study measures.
- Research participant is able to speak and read English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
Related Links
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Sean Phipps, PhD
St. Jude Children's Research Hospital
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 15, 2011
First Posted
November 22, 2011
Study Start
December 1, 2011
Primary Completion
March 1, 2016
Study Completion
March 1, 2016
Last Updated
April 8, 2016
Record last verified: 2016-04